IN181999B - - Google Patents
Info
- Publication number
- IN181999B IN181999B IN1755CA1996A IN181999B IN 181999 B IN181999 B IN 181999B IN 1755CA1996 A IN1755CA1996 A IN 1755CA1996A IN 181999 B IN181999 B IN 181999B
- Authority
- IN
- India
- Prior art keywords
- methods
- agents
- alone
- combination
- beta
- Prior art date
Links
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- 230000003211 malignant effect Effects 0.000 abstract 2
- 239000000651 prodrug Substances 0.000 abstract 2
- 229940002612 prodrug Drugs 0.000 abstract 2
- 208000011580 syndromic disease Diseases 0.000 abstract 2
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 abstract 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 abstract 1
- 108010044495 Fetal Hemoglobin Proteins 0.000 abstract 1
- 108091005886 Hemoglobin subunit gamma Proteins 0.000 abstract 1
- 102100038617 Hemoglobin subunit gamma-2 Human genes 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000005980 beta thalassemia Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000014951 hematologic disease Diseases 0.000 abstract 1
- 208000034737 hemoglobinopathy Diseases 0.000 abstract 1
- 208000018337 inherited hemoglobinopathy Diseases 0.000 abstract 1
- 239000004310 lactic acid Substances 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
- C07C69/68—Lactic acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/540,345 US5883123A (en) | 1995-10-06 | 1995-10-06 | Butyrate prodrugs derived from lactic acid |
| US08/640,260 US5912269A (en) | 1996-04-30 | 1996-04-30 | Butyrate prodrugs derived from lactic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN181999B true IN181999B (de) | 1998-11-28 |
Family
ID=27066414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1755CA1996 IN181999B (de) | 1995-10-06 | 1996-10-04 |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0863866B1 (de) |
| JP (1) | JPH11512743A (de) |
| KR (1) | KR19990063988A (de) |
| CN (1) | CN1201447A (de) |
| AT (1) | ATE200893T1 (de) |
| AU (1) | AU718983B2 (de) |
| BR (1) | BR9610850A (de) |
| CA (1) | CA2233606A1 (de) |
| DE (1) | DE69612671T2 (de) |
| DK (1) | DK0863866T3 (de) |
| ES (1) | ES2158351T3 (de) |
| GR (1) | GR3035899T3 (de) |
| IN (1) | IN181999B (de) |
| NZ (1) | NZ319877A (de) |
| PT (1) | PT863866E (de) |
| RU (1) | RU2175967C2 (de) |
| TW (1) | TW422834B (de) |
| WO (1) | WO1997012855A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5880152A (en) * | 1995-10-06 | 1999-03-09 | Vertex Pharmaceuticals, Inc. | Butyrate prodrugs derived from lactic acid |
| US6225350B1 (en) | 1998-03-10 | 2001-05-01 | Vertex Pharmaceuticals, Inc. | Butyrate prodrugs derived from lactic acid |
| US6878361B2 (en) | 2001-07-10 | 2005-04-12 | Battelle Memorial Institute | Production of stable aqueous dispersions of carbon nanotubes |
| US6896864B2 (en) | 2001-07-10 | 2005-05-24 | Battelle Memorial Institute | Spatial localization of dispersed single walled carbon nanotubes into useful structures |
| DE60304989T2 (de) | 2003-02-18 | 2007-03-29 | Clinique La Prairie Research S.A. | Zusammensetzungen enthaltend fötales Hämoglobin und bakterielles Endotoxin und fakultativ zusätzliche fötale Leberkomponenten |
| EP1658074B1 (de) * | 2003-08-01 | 2012-11-07 | Fibrogen, Inc. | 2-oxoglutarat-oxygenase-hemmer als induktor des gammaglobins |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE277700C (de) * | ||||
| GB603189A (en) * | 1945-10-22 | 1948-06-10 | Howards & Sons Ltd | Manufacture of acyloxy-carboxylic acids |
| DE824041C (de) * | 1945-10-22 | 1951-12-10 | Howards & Sons Ltd | Verfahren zur Herstellung von aliphatischen a -Acyloxymonocarbonsaeuren |
| US2464992A (en) * | 1946-10-10 | 1949-03-22 | Chessie E Rehberg | Esters of acyloxycarboxylic acids |
| FR1578064A (de) * | 1968-05-20 | 1969-08-14 | ||
| US5091560A (en) * | 1988-03-14 | 1992-02-25 | The Clorox Company | Method for synthesizing acyloxycarboxylic acids |
| US5252473A (en) * | 1990-01-23 | 1993-10-12 | Battelle Memorial Institute | Production of esters of lactic acid, esters of acrylic acid, lactic acid, and acrylic acid |
| NL9200481A (nl) * | 1992-03-13 | 1993-10-01 | Univ Groningen | Farmaceutisch preparaat met plaatsgerichte afgifte. |
| JPH08113795A (ja) * | 1994-10-14 | 1996-05-07 | T Hasegawa Co Ltd | 香料組成物 |
-
1996
- 1996-09-30 AT AT96933967T patent/ATE200893T1/de not_active IP Right Cessation
- 1996-09-30 RU RU98108450/04A patent/RU2175967C2/ru not_active IP Right Cessation
- 1996-09-30 PT PT96933967T patent/PT863866E/pt unknown
- 1996-09-30 CA CA002233606A patent/CA2233606A1/en not_active Abandoned
- 1996-09-30 CN CN96197978A patent/CN1201447A/zh active Pending
- 1996-09-30 NZ NZ319877A patent/NZ319877A/en unknown
- 1996-09-30 KR KR1019980702463A patent/KR19990063988A/ko not_active Withdrawn
- 1996-09-30 JP JP9514352A patent/JPH11512743A/ja not_active Ceased
- 1996-09-30 ES ES96933967T patent/ES2158351T3/es not_active Expired - Lifetime
- 1996-09-30 EP EP96933967A patent/EP0863866B1/de not_active Expired - Lifetime
- 1996-09-30 DE DE69612671T patent/DE69612671T2/de not_active Expired - Lifetime
- 1996-09-30 DK DK96933967T patent/DK0863866T3/da active
- 1996-09-30 WO PCT/US1996/015660 patent/WO1997012855A1/en not_active Ceased
- 1996-09-30 BR BR9610850A patent/BR9610850A/pt not_active Application Discontinuation
- 1996-09-30 AU AU72498/96A patent/AU718983B2/en not_active Ceased
- 1996-10-04 IN IN1755CA1996 patent/IN181999B/en unknown
- 1996-10-05 TW TW085112196A patent/TW422834B/zh not_active IP Right Cessation
-
2001
- 2001-05-18 GR GR20010400754T patent/GR3035899T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TW422834B (en) | 2001-02-21 |
| WO1997012855A1 (en) | 1997-04-10 |
| DE69612671D1 (de) | 2001-06-07 |
| AU718983B2 (en) | 2000-05-04 |
| DK0863866T3 (da) | 2001-06-11 |
| DE69612671T2 (de) | 2004-08-05 |
| JPH11512743A (ja) | 1999-11-02 |
| ATE200893T1 (de) | 2001-05-15 |
| HK1016153A1 (en) | 1999-10-29 |
| NZ319877A (en) | 1999-09-29 |
| EP0863866B1 (de) | 2001-05-02 |
| CN1201447A (zh) | 1998-12-09 |
| AU7249896A (en) | 1997-04-28 |
| KR19990063988A (ko) | 1999-07-26 |
| RU2175967C2 (ru) | 2001-11-20 |
| CA2233606A1 (en) | 1997-04-10 |
| PT863866E (pt) | 2001-09-28 |
| EP0863866A1 (de) | 1998-09-16 |
| GR3035899T3 (en) | 2001-08-31 |
| BR9610850A (pt) | 1999-07-13 |
| ES2158351T3 (es) | 2001-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2223510A1 (en) | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease | |
| MXPA02005510A (es) | Compuestos, composiciones y metodos para estimular el crecimiento y alargamiento neuronal. | |
| PT804252E (pt) | Agentes queladores metalicos que contem monoaminas diamidas e tiois | |
| GB2305107B (en) | Biological materials preserved by antioxidant synthetic catalytic free radical scavengers | |
| CA2294247A1 (en) | Antioxidant enhancement of therapy for hyperproliferative conditions | |
| UA39158C2 (uk) | Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі | |
| EP1820862A3 (de) | Medizinische Präparate zur Behandlung von Alpha-Galaktosidase-A-Mangel | |
| TR200101124T2 (tr) | N-(2-aril-propiyonil)-sülfonamidler ve bunları içeren farmasötik preparasyonlar. | |
| BG104679A (en) | The use of fumaric acid derivatives in transplant medicine | |
| AU3216893A (en) | Methods for admininstration of taxol | |
| CA2057048A1 (en) | Vitamin d analogues | |
| HU9601740D0 (en) | Compounds with growth hormone releasing properties | |
| JO2373B1 (en) | W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors | |
| IL140684A0 (en) | Medicine nitrate salts | |
| BG104599A (en) | Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas | |
| CA2388939A1 (en) | Therapeutic treatments for blood cell deficiencies | |
| CA2148194A1 (en) | Cyclopeptides of the formula i | |
| ATE314065T1 (de) | Threitol-buttersäureester-enthaltende zusammensetzungen und ihre verwendung | |
| CA2213322A1 (en) | Thiols to promote hematopoietic progenitor cell growth | |
| CA2169173A1 (en) | Methods for stimulating erythropoiesis using thrombopoietin | |
| IL126235A (en) | Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use | |
| MX9504023A (es) | Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion. | |
| AU6450098A (en) | Butyrate prodrugs derived from lactic acid | |
| GR3035899T3 (en) | Butyrate prodrugs of lactic acid | |
| CA2155017A1 (en) | Vpr function and activity |